Anuh Pharma Ltd. Share Price & Stock Analysis

Anuh Pharma Ltd. (BSE: 506260) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹829 Cr, it ranks #1,686 by market cap among the 6,197 Indian listed companies on FinBizNet, and #49 of 86 in Medicinal Chemicals and Botanical Products. At ₹82.50 (as of 16 Nov 2026), the share price is 17.1% below its 52-week high of ₹99.50 and 23.1% above its 52-week low of ₹67.00. The share price is down 4.0% over one year and up 7.1% over three months.

Key Metrics

Current Price₹82.50
Market Cap₹829 Cr
BSE Code506260
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio20.2
Return on Equity12.10%
Return on Assets6.63%
52-Week Range₹67.00 – ₹99.50
1-Year Price Change-4.0%
3-Month Price Change+7.1%
Beta (1Y)0.3
Dividend Yield1.81%
HeadquartersMumbai, Maharashtra
Websitewww.anuhpharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹185 Cr
Net Profit₹11 Cr
Net Margin6.1%
EPS (Basic)₹1.12
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Anuh Pharma Ltd. Quarterly Revenue and Profit Trend

Anuh Pharma Ltd. reported revenue of ₹185 Cr in Q2 FY27, down 0.3% from ₹186 Cr in Q2 FY26 and down 4.4% from ₹194 Cr in Q1 FY27. It posted a net profit of ₹11 Cr for the quarter, against a net profit of ₹8 Cr in Q2 FY26 (up 47.3%). Across the 8 quarters from Q3 FY25 to Q2 FY27, quarterly revenue ranged from ₹160 Cr (Q3 FY25) to ₹202 Cr (Q4 FY26). The company was profitable in each of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹185 Cr₹11 Cr6.1%
Q1 FY27₹194 Cr₹11 Cr5.9%
Q4 FY26₹202 Cr₹12 Cr5.8%
Q3 FY26₹197 Cr₹13 Cr6.8%
Q2 FY26₹186 Cr₹8 Cr4.1%
Q1 FY26₹186 Cr₹8 Cr4.5%
Q4 FY25₹198 Cr₹12 Cr6.3%
Q3 FY25₹160 Cr₹10 Cr6.5%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 71.80% of Anuh Pharma Ltd.'s shares as of Sept 2026, against 71.82% in Sept 2025 (−0.02 percentage points). Delivery averaged 54.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Anuh Pharma Ltd.

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

Products and Services

1. Bulk Drug and Chemicals-This segment manufactures and sells bulk drugs and chemicals.

Business Segments

1. Bulk Drug and Chemicals-100%

Anuh Pharma Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Anuh Pharma Ltd.₹829 Cr20.212.10%₹185 Cr-4.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Anuh Pharma Ltd.?

Anuh Pharma Ltd. is trading at ₹82.50, with a market capitalisation of ₹829 Cr.

Which sector does Anuh Pharma Ltd. belong to?

Anuh Pharma Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Anuh Pharma Ltd.?

Anuh Pharma Ltd. has a P/E of 20.2 and a return on equity of 12.10%.

What is the stock symbol of Anuh Pharma Ltd.?

Anuh Pharma Ltd. is listed on the BSE under the scrip code 506260.

How has Anuh Pharma Ltd.'s share price moved over the past year?

Anuh Pharma Ltd.'s share price is down 4.0% over one year and up 7.1% over three months. Its 52-week range is ₹67.00 to ₹99.50.

What were Anuh Pharma Ltd.'s latest quarterly results?

In Q2 FY27, Anuh Pharma Ltd. reported revenue of ₹185 Cr and net profit of ₹11 Cr, with basic EPS of ₹1.12 (standalone, parsed from the company's exchange filing).

How have Anuh Pharma Ltd.'s revenue and profit changed over the past year?

Anuh Pharma Ltd. reported revenue of ₹185 Cr in Q2 FY27, down 0.3% from ₹186 Cr in Q2 FY26 and down 4.4% from ₹194 Cr in Q1 FY27.

What is the promoter holding in Anuh Pharma Ltd.?

Promoters held 71.80% of Anuh Pharma Ltd.'s shares as of Sept 2026, against 71.82% in Sept 2025 (−0.02 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.